Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6months - Results from a randomized clinical trial

Growth Hormone and IGF Research

Volumn 23, Issue 5, 2013, Pages 149-158

  Rzehak, Peter ^a   Grote, Veit ^a   Lattka, Eva ^b   Weber, Martina ^a   Gruszfeld, Dariusz ^c   Socha, Piotr ^c   Closa Monasterolo, Ricardo ^d   Escribano, Joaquín ^d   Giovannini, Marcello ^e   Verduci, Elvira ^e   Goyens, Philippe ^f   Martin, Françoise ^g   Langhendries, Jean Paul ^g   Demmelmair, Hans ^a   Klopp, Norman ^b,h   Illig, Thomas ^b,h   Koletzko, Berthold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^g CHC St Vincent ^*  (Belgium)

^h HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

European Childhood Obesity Trial Study; IGF 1 gene; IGF I concentration; IGFBP 3 variants; Protein formula; Randomized clinical trial

Indexed keywords

MILK PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; ARTIFICIAL MILK; BODY WEIGHT; BREAST FEEDING; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; INSULIN LIKE GROWTH FACTOR 1 GENE; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 GENE; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM;

EUROPEAN CHILDHOOD OBESITY TRIAL STUDY; IGF-1 GENE; IGF-I CONCENTRATION; IGFBP-3 VARIANTS; PROTEIN FORMULA; RANDOMIZED CLINICAL TRIAL;

AGE FACTORS; BREAST FEEDING; EATING; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HUMANS; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; MALE; MILK PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84882917384     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2013.05.002     Document Type: Article

References (41)

1. Backeljauw P., Bang P., Dunger D.B., Juul A., Le Bouc Y., Rosenfeld R. Insulin-like growth factor-I in growth and metabolism. J. Pediatr. Endocrinol. Metab. 2010, 23:3-16.
2. Le Roith D., Scavo L., Butler A. What is the role of circulating IGF-I?. Trends Endocrinol. Metab. 2001, 12:48-52.
3. Baxter R.C. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E967-E976.
4. Clemmons D.R. IGF binding proteins and their functions. Mol. Reprod. Dev. 1993, 35:368-374. (discussion 374-375).
5. Madsen A.L., Larnkjær A., Mølgaard C., Michaelsen K.F. IGF-I and IGFBP-3 in healthy 9months old infants from the SKOT cohort: breastfeeding, diet, and later obesity. Growth Horm. IGF Res. 2011, 21:199-204.
6. Ketelslegers J.-M., Maiter D., Maes M., Underwood L.E., Thissen J.-P. Nutritional regulation of insulin-like growth factor-I. Metabolism 1995, 44(Suppl. 4):50-57.
7. Rogers I., Emmett P., Gunnell D., Dunger D., Holly J. Milk as a food for growth? The insulin-like growth factors link. Public Health Nutr. 2006, 9:359-368.
8. Dupuis J., Langenberg C., Prokopenko I., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 42:105-116.
9. Harrela M., Koistinen H., Kaprio J., et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J. Clin. Invest. 1996, 98:2612-2615.
10. Kaplan R.C., Petersen A.-K., Chen M.-H., et al. A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum. Mol. Genet. 2011, 20:1241-1251.
11. Patel A., Cheng I., Canzian F., Le M., Thun M., Berg C. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 2008, 3:e2578.
12. Schumacher F.R., Cheng I., Freedman M.L., et al. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum. Mol. Genet. 2010, 19:3089-3101.
13. Taverne C., Verheus M., McKay J., et al. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Breast Cancer Res. Treat. 2010, 123:843-855.
14. Terry K.L., Tworoger S.S., Gates M.A., Cramer D.W., Hankinson S.E. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Carcinogenesis 2009, 30:2042-2046.
15. Verheus M., McKay J.D., Kaaks R., et al. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. Breast Cancer Res. Treat. 2008, 112:109-122.
16. Johnston L.B., Dahlgren J., Leger J., et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J. Clin. Endocrinol. Metab. 2003, 88:4805-4810.
17. Kaay D.C.M.v.d., Hendriks A.E.J., Ester W.A., et al. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): Correlation with serum IGFBP-3 levels and growth in short children born small for gestational age. Growth Horm. IGF Res. 2009, 19:198-205.
18. Vella A., Bouatia-Naji N., Heude B., et al. Association analysis of the IGF1 gene with childhood growth, IGF-1 concentrations and type 1 diabetes. Diabetologia 2008, 51:811-815.
19. Elmlinger M.W., Kühnel W., Weber M.M., Ranke M.B. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin. Chem. Lab. Med. 2004, 42:654-664.
20. Jensen R.B., Jeppesen K.A., Vielwerth S., et al. Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 as diagnostic markers of growth hormone deficiency in infancy. Horm. Res. Paediatr. 2005, 63:15-21.
21. Kawai N., Kanzaki S., Takano-Watou S., et al. Serum free insulin-like growth factor i (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency. J. Clin. Endocrinol. Metab. 1999, 84:82-89.
22. Yuksel B., Ozbek M.N., Mungan N.O., et al. Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6years of age. J. Clin. Res. Pediatr. Endocrinol. 2011, 3:84-88.
23. Hoppe C., Rovenna Udam T., Lauritzen L., Mølgaard C., Juul A., Fleischer Michaelsen K. Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-y-old Danish children. Am. J. Clin. Nutr. 2004, 80:447-452.
24. Socha P., Grote V., Gruszfeld D., et al. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. Am. J. Clin. Nutr. 2011, 94:1776S-1784S. (Suppl.).
25. Koletzko B., von Kries R., Closa R., et al. Lower protein in infant formula is associated with lower weight up to age 2y: a randomized clinical trial. Am. J. Clin. Nutr. 2009, 89:1836-1845.
26. European Commission Commission Directive 91/321/EEC of 14 May 1991 on infant formulae and follow-on formulae. Off. J. Eur. Union 1991, 35-49.
27. Aggett P.J., Agostini C., Goulet O., et al. The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2001, 32:256-258.
28. Scientific Committee on Food Report of the Scientific Committee on Food on the revision of essential requirements of infant formulae and follow-on formulae 2003, European Commission, Brussels, Belgium.
29. Committee on the Evaluation of the Addition of Ingredients New to Infant Formula. Comparing infant formula with human milk, infant formula: evaluation of the safety of new ingredients 2004, 49-66. The National Academies Press, Washington, DC.
30. Moher D., Schulz K.F., Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA-J. Am. Med. Assoc. 2001, 285:1987-1991.
31. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J. Clin. Epidemiol. 2010, 63:834-840.
32. Hoppe C., Molgaard C., Juul A., Michaelsen K.F. High intakes of skimmed milk, but not meat, increase serum IGF-I and IGFBP-3 in eight-year-old boys. Eur. J. Clin. Nutr. 2004, 58:1211-1216.
33. Geary M.P., Pringle P.J., Rodeck C.H., Kingdom J.C., Hindmarsh P.C. Sexual dimorphism in the growth hormone and insulin-like growth factor axis at birth. J. Clin. Endocrinol. Metab. 2003, 88:3708-3714.
34. Carter K.W., McCaskie P.A., Palmer L.J. JLIN: a java based linkage disequilibrium plotter. BMC Bioinforma. 2006, 7:60. (http://www.biomedcentral.com/1471-2105/7/60).
35. SAS Institute Inc. SAS/STAT 9.2 User's Guide 2009, SAS Institue Inc., Cary, NC. Second ed.
36. Ben-Shlomo Y., Holly J., McCarthy A., Savage P., Davies D., Davey Smith G. Prenatal and postnatal milk supplementation and adult insulin-like growth factor I: long-term follow-up of a randomized controlled trial. Cancer Epidemiol. Biomark. Prev. 2005, 14:1336-1339.
37. Larnkjaer A., Ingstrup H.K., Schack-Nielsen L., et al. Early programming of the IGF-I axis: Negative association between IGF-I in infancy and late adolescence in a 17-year longitudinal follow-up study of healthy subjects. Growth Horm. IGF Res. 2009, 19:82-86.
38. Deal C., Ma J., Wilkin F., Paquette J., Rozen F., Ge B., Hudson T., Stampfer M., Pollak M. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J. Clin. Endocrinol. Metab. 2001, 86:1274-1280.
39. Chellakooty M., Juul A., Boisen K.A., et al. A prospective study of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in 942 healthy infants: associations with birth weight, gender, growth velocity, and breastfeeding. J. Clin. Endocrinol. Metab. 2006, 91:820-826.
40. Savino F., Fissore M.F., Grassino E.C., Nanni G.E., Oggero R., Silvestro L. Ghrelin, leptin and IGF-I levels in breast-fed and formula-fed infants in the first years of life. Acta Paediatr. 2005, 94:531-537.
41. Nommsen L., Lovelady C., Heinig M., Lonnerdal B., Dewey K. Determinants of energy, protein, lipid, and lactose concentrations in human milk during the first 12 mo of lactation: the DARLING Study. Am. J. Clin. Nutr. 1991, 53:457-465.